with Element one of a new generation of rivals alongside the likes of PacBio and Singular Genomics, which launched their Onso and G4 instruments in 2022 and 2021, respectively. Element’s Series ...

In a report released today, Luke Sergott from Barclays maintained a Hold rating on Pacific Biosciences (PACB – Research Report), with a price target of $2.00. The company’s shares closed ...

While the top- and bottom-line numbers for Pacific Biosciences (PACB) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Pacific Biosciences (PACB – Research Report), Immunovant (IMVT – Research Report) and 4D ...

Pacific allies don’t usually air their dirty laundry in public. But a rare on-the-record dispute between New Zealand and Kiribati has renewed focus on the poor and isolated island nation ...

More than 10 million devout Hindus seeking absolution from their sins took a dip in holy waters in northern India during a span of four hours on Wednesday, authorities said, as they braced for ...

We hoped industry layoffs would relent in 2024. That's not what happened. Overall, biopharma layoffs rose 3% last year compared to 2023, according to an analysis of yearly data. So, here we are ...